• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    35 Stocks Moving In Monday's Mid-Day Session

    1/3/22 12:06:05 PM ET
    $AFI
    $AGE
    $APLT
    $ASRT
    Building Products
    Capital Goods
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AFI alert in real time by email

    Gainers

    • Immix Biopharma, Inc. (NASDAQ:IMMX) shares climbed 110.3% to $7.32. The FDA granted Rare Pediatric Disease (RPD) designation to newly listed Immix Biopharma's IMX-110 for rhabdomyosarcoma, a form of pediatric cancer.
    • Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) gained 48.6% to $3.2850. The stock may be seeing increased interested from retail investors.
    • Pear Therapeutics, Inc. (NASDAQ:PEAR) shares climbed 34.7% to $8.35. BTIG initiated coverage on Pear Therapeutics with a Buy rating and announced a price target of $12.
    • Armstrong Flooring, Inc. (NYSE:AFI) rose 25.3% to $2.48 as the company said it received $35 million capital infusion, and announced process for sale of company and consideration of other strategic alternatives.
    • Nuverra Environmental Solutions, Inc. (NASDAQ:NES) gained 24% to $3.7696.
    • Applied UV, Inc. (NASDAQ:AUVI) surged 17.7% to $3.18. Applied UV recently announced closing of $8.0 million underwritten public offering.
    • Jowell Global Ltd. (NASDAQ:JWEL) gained 16.9% to $25.20.
    • Gilat Satellite Networks Ltd. (NASDAQ:GILT) gained 15.6% to $8.17 as the company said one of the world’s largest Mobile Network Operators will deploy 4G cellular backhaul over satellite technology from Gilat..
    • BlueCity Holdings Limited (NASDAQ:BLCT) rose 15.7% to $1.77 after the company announced it received an acquisition offer for the company at $3.70 per share.
    • Nam Tai Property Inc. (NYSE:NTP) gained 15.5% to $11.65.
    • Assertio Holdings, Inc. (NASDAQ:ASRT) jumped 14.2% to $2.49.
    • Orbsat Corp. (NASDAQ:OSAT) surged 13.7% to $3.6750 as the company reported a $7.2 million private placement.
    • Theravance Biopharma, Inc. (NASDAQ:TBPH) gained 13.1% to $12.50.
    • Uranium Energy Corp. (NYSE:UEC) rose 12.8% to $3.78. Uranium Energy, last month, posted a Q1 loss of $0.01 per share.
    • Immunic, Inc. (NASDAQ:IMUX) gained 12.7% to $10.78.
    • Uranium Royalty Corp. (NASDAQ:UROY) surged 12.7% to $4.1142.
    • Signet Jewelers Limited (NYSE:SIG) gained 11.9% to $97.43.
    • Moxian (BVI) Inc (NASDAQ:MOXC) jumped 11.8% to $3.20.
    • Groupon, Inc. (NASDAQ:GRPN) shares rose 10.7% to $25.64.
    • Gevo, Inc. (NASDAQ:GEVO) gained 10% to $4.71.
    • Tesla, Inc. (NASDAQ:TSLA) jumped 9% to $1,152.02 as the company reported record quarterly and annual deliveries that exceeded the most optimistic Wall Street forecasts.
    • Frontline Ltd. (NYSE:FRO) rose 7.2% to $7.58. Frontline, in November, reported third-quarter operating revenue of $171.8 million, a decline of 30.6% year-over-year.

    Check out these big penny stock gainers and losers

    Losers

    • uCloudlink Group Inc. (NASDAQ:UCL) fell 28.7% to $4.70 after climbing 32% on Friday.
    • Applied Therapeutics, Inc. (NASDAQ:APLT) shares dipped 28.3% to $6.42. Following discussions with the FDA, Applied Therapeutics decided to hold on submitting a marketing application for AT-007 for Galactosemia pending additional talks with the agency.
    • AgeX Therapeutics, Inc. (NASDAQ:AGE) fell 16.1% to $0.9151 after jumping 85% on Friday. AgeX Therapeutics recently announced plans to collaborate with University of California, Irvine, on research program for exosome-based therapies for certain brain disorders.
    • CNH Industrial N.V. (NYSE:CNHI) shares fell 13.9% to $16.73. CNH Industrial NV and Iveco Group executed the deed of demerger whereby, effective January 1, 2022, the relevant Iveco Group business segments separated from CNH Industrial.
    • Himax Technologies, Inc. (NASDAQ:HIMX) fell 12% to $14.07.
    • Heliogen, Inc. (NASDAQ:HLGN) dropped 11.7% to $13.70 after jumping around 62% on Friday.
    • Fathom Digital Manufacturing Corporation (NYSE:FATH) dropped 11.1% to $7.04 after surging 22% on Friday.
    • Nutriband Inc. (NASDAQ:NTRB) fell 9.9% to $9.08. Nutriband shares climbed 158% on Friday after the company announced the Korean Intellectual Property Office has fully issued its patent titled "Abuse and Misuse Deterrent Transdermal System" which is related to the company's lead technology AVERSA.
    • Medalist Diversified REIT, Inc. (NASDAQ:MDRR) shares fell 8.8% to $1.0950. Medalist Diversified REIT shares jumped around 18% on Friday after the company announced a stock repurchase program of 500,000 shares.
    • MongoDB, Inc. (NASDAQ:MDB) fell 8% to $486.97.
    • SuperCom Ltd (NASDAQ:SPCB) fell 7.6% to $0.5126 after declining around 9% on Friday.
    • Moderna, Inc. (NASDAQ:MRNA) declined 7.1% to $235.85. Moderna recently announced supply agreement with South Korea for additional 20 million doses of its COVID-19 vaccine or updated booster candidate in 2022.
    • Kingsoft Cloud Holdings Limited (NASDAQ:KC) dropped 7% to $14.70. Goldman Sachs downgraded Kingsoft Cloud from Buy to Neutral and lowered the price target from $37 to $18.
    Get the next $AFI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AFI
    $AGE
    $APLT
    $ASRT

    CompanyDatePrice TargetRatingAnalyst
    Tesla Inc.
    $TSLA
    4/24/2026$385.00Sell → Hold
    DZ Bank
    Uranium Royalty Corp.
    $UROY
    4/21/2026Mkt Perform → Outperform
    Raymond James
    Tesla Inc.
    $TSLA
    4/20/2026$300.00 → $350.00Hold
    Jefferies
    Immunic Inc.
    $IMUX
    4/17/2026$2.50Buy
    Stifel
    Immunic Inc.
    $IMUX
    4/15/2026Buy → Hold
    D. Boral Capital
    Tesla Inc.
    $TSLA
    4/14/2026$352.00Sell → Neutral
    UBS
    Tesla Inc.
    $TSLA
    4/13/2026$500.00 → $480.00Outperform
    RBC Capital Mkts
    Assertio Holdings Inc.
    $ASRT
    4/9/2026$18.00Buy → Neutral
    H.C. Wainwright
    More analyst ratings

    $AFI
    $AGE
    $APLT
    $ASRT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CHAIRMAN, CEO & PRESIDENT Kavanaugh Frank bought $600,000 worth of shares (40,000 units at $15.00), increasing direct ownership by 7% to 646,177 units (SEC Form 4)

    4 - Medalist Diversified, Inc. (0001654595) (Issuer)

    3/13/26 4:15:11 PM ET
    $MDRR
    Real Estate Investment Trusts
    Real Estate

    CHIEF FINANCIAL OFFICER Winn Charles Brent Jr. bought $13,613 worth of shares (1,188 units at $11.46), increasing direct ownership by 2% to 60,390 units (SEC Form 4)

    4 - Medalist Diversified REIT, Inc. (0001654595) (Issuer)

    3/6/26 4:08:07 PM ET
    $MDRR
    Real Estate Investment Trusts
    Real Estate

    CHAIRMAN, CEO & PRESIDENT Kavanaugh Frank bought $33,541 worth of shares (2,582 units at $12.99), increasing direct ownership by 0.86% to 302,177 units (SEC Form 4)

    4 - Medalist Diversified REIT, Inc. (0001654595) (Issuer)

    12/15/25 8:53:49 AM ET
    $MDRR
    Real Estate Investment Trusts
    Real Estate

    $AFI
    $AGE
    $APLT
    $ASRT
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    November 30, 2020 - Coronavirus (COVID-19) Update: FDA Announces Advisory Committee Meeting to Discuss Second COVID-19 Vaccine Candidate

    For Immediate Release: November 30, 2020 The U.S. Food and Drug Administration has scheduled a meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Dec. 17 to discuss the request for emergency use authorization (EUA) for a COVID-19 vaccine from Moderna, Inc. “In keeping with the FDA’s commitment to ensuring full transparency, dialogue and efficiency, the Vaccines and Related Biological Products Advisory Comm

    11/30/20 5:12:14 PM ET
    $MRNA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AFI
    $AGE
    $APLT
    $ASRT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Tesla upgraded by DZ Bank with a new price target

    DZ Bank upgraded Tesla from Sell to Hold and set a new price target of $385.00

    4/24/26 8:02:36 AM ET
    $TSLA
    Auto Manufacturing
    Industrials

    Uranium Royalty upgraded by Raymond James

    Raymond James upgraded Uranium Royalty from Mkt Perform to Outperform

    4/21/26 7:24:01 AM ET
    $UROY
    Investment Bankers/Brokers/Service
    Finance

    Jefferies reiterated coverage on Tesla with a new price target

    Jefferies reiterated coverage of Tesla with a rating of Hold and set a new price target of $350.00 from $300.00 previously

    4/20/26 9:26:12 AM ET
    $TSLA
    Auto Manufacturing
    Industrials

    $AFI
    $AGE
    $APLT
    $ASRT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    SuperCom to Report Fourth Quarter and Full Year 2025 Financial Results on April 28th, 2026

    TEL AVIV, Israel, April 23, 2026 /PRNewswire/ -- SuperCom (NASDAQ:SPCB), a global provider of secured solutions for the e-Government, IoT and Cybersecurity sectors, will hold a conference call on Tuesday, April 28, 2026, at 10 a.m. Eastern time (7 a.m. Pacific Time / 5 p.m. IL time) to discuss its financial results for the fourth quarter and year ended December 31, 2025. Financial results will be issued in a press release prior to the call. SuperCom management will host the conference call, followed by a question-and-answer period.Conference Call Dial-In Information:Date: Tuesday, April 28, 2026Time: 10 a.m. Eastern time (7 a.m. Pacific time)U.S. toll-free: 888-506-0062Israel toll-free: 1-80

    4/23/26 9:28:00 AM ET
    $SPCB
    Semiconductors
    Technology

    Energy Constraints Emerging as Critical Factor in Sustaining AI Expansion

    AUSTIN, Texas, April 23, 2026 (GLOBE NEWSWIRE) -- AINewsWire Editorial Coverage: Artificial intelligence is no longer confined to software innovation; it is increasingly becoming an energy-intensive phenomenon. As AI systems grow in size and sophistication, the computational requirements needed to train and run them are triggering a sharp rise in electricity consumption, one that is beginning to strain existing infrastructure. Data centers, once considered purely digital enablers, are now among the most power-demanding assets in the global economy. This evolution is prompting governments, utilities and private enterprises alike to reassess a critical constraint: the limiting factor in AI's

    4/23/26 8:30:00 AM ET
    $DUK
    $GEV
    $NEE
    Power Generation
    Utilities
    EDP Services
    Technology

    Immunic, Inc. Announces 1-for-10 Reverse Stock Split

    NEW YORK, April 23, 2026 /PRNewswire/ -- Immunic, Inc. (NASDAQ:IMUX), a late-stage biotechnology company pioneering the development of novel oral therapies for neurologic diseases (the "Company" or "Immunic"), today announced that it will effect a reverse stock split of its outstanding shares of common stock, effective as of 12:01 a.m. Eastern Time on April 27, 2026.Immunic's common stock will continue to be traded on the Nasdaq Capital Market under the symbol "IMUX" and will begin trading on a reverse stock split-adjusted basis at the opening of the Nasdaq Capital Market on April 27, 2026. The new CUSIP number for the split-adjusted common stock will be 4525EP200.At the Company's special me

    4/23/26 8:00:00 AM ET
    $IMUX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AFI
    $AGE
    $APLT
    $ASRT
    SEC Filings

    View All

    SEC Form 6-K filed by Kingsoft Cloud Holdings Limited

    6-K - Kingsoft Cloud Holdings Ltd (0001795589) (Filer)

    4/23/26 7:28:22 PM ET
    $KC
    Computer Software: Prepackaged Software
    Technology

    SEC Form 6-K filed by Kingsoft Cloud Holdings Limited

    6-K - Kingsoft Cloud Holdings Ltd (0001795589) (Filer)

    4/23/26 8:51:55 AM ET
    $KC
    Computer Software: Prepackaged Software
    Technology

    Immunic Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits

    8-K - IMMUNIC, INC. (0001280776) (Filer)

    4/23/26 8:30:43 AM ET
    $IMUX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AFI
    $AGE
    $APLT
    $ASRT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO Musk Elon returned 96,000,000 shares to the company, decreasing direct ownership by 18% to 423,743,904 units (SEC Form 4)

    4 - Tesla, Inc. (0001318605) (Issuer)

    4/23/26 4:05:10 PM ET
    $TSLA
    Auto Manufacturing
    Industrials

    SEC Form 3 filed by new insider Trabelsi Barak

    3 - SuperCom Ltd (0001291855) (Issuer)

    4/20/26 5:30:18 PM ET
    $SPCB
    Semiconductors
    Technology

    SEC Form 4 filed by Kavanaugh Frank

    4 - Medalist Diversified, Inc. (0001654595) (Issuer)

    4/17/26 8:46:27 AM ET
    $MDRR
    Real Estate Investment Trusts
    Real Estate

    $AFI
    $AGE
    $APLT
    $ASRT
    Leadership Updates

    Live Leadership Updates

    View All

    Gevo Appoints Joan Cetera as Vice President, Communications and Public Relations

    ENGLEWOOD, Colo., April 13, 2026 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ:GEVO), a leader in renewable fuels and chemicals and carbon management, today announced the appointment of Joan Cetera as Vice President of Communications and Public Relations, further supporting Gevo's broader leadership transition. Joan brings extensive experience leading enterprise communications for publicly traded companies, with expertise spanning executive communications, reputational management and communications strategy during periods of organizational change. Over her more than 20-year career, she has partnered closely with senior leadership teams to align external perception with business strategy and stak

    4/13/26 4:01:00 PM ET
    $GEVO
    Major Chemicals
    Industrials

    Gevo Appoints Key Executive Team Members

    ENGLEWOOD, Colo., April 01, 2026 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ:GEVO), a leader in renewable fuels, chemicals, and carbon management, today announced the appointments of Kyle James as Chief Commercial Officer and Dave Kettner as General Counsel, further supporting Gevo's broader leadership transition. The executive additions round out newly appointed Chief Executive Officer Paul Bloom's executive team, increasing expertise across renewable fuels, chemicals and value-driven commercial strategies and expanding the company's legal expertise and first-hand experience scaling renewable fuels and technology businesses. "I am excited to welcome Kyle and Dave to Gevo. Kyle's deep experien

    4/1/26 9:00:00 AM ET
    $GEVO
    Major Chemicals
    Industrials

    Immunic Strengthens Its Board of Directors with the Appointment of Seasoned Biopharmaceutical Executive Jon Congleton

    – Nearly 40-Year Biopharmaceutical Professional with Deep CNS and Commercial Leadership Experience in Multiple Sclerosis –– Served on Original Team Responsible for the Launch of Copaxone® in the United States –NEW YORK, March 31, 2026 /PRNewswire/ -- Immunic, Inc. (NASDAQ:IMUX), a late-stage biotechnology company pioneering the development of novel oral therapies for neurologic diseases, today announced the appointment of Jon Congleton, a seasoned biopharmaceutical executive with nearly 40 years of experience spanning drug development, commercialization and corporate leadership, to its Board of Directors, effective March 27, 2026.Mr. Congleton has a strong track record of building and leadin

    3/31/26 6:30:00 AM ET
    $IMUX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AFI
    $AGE
    $APLT
    $ASRT
    Financials

    Live finance-specific insights

    View All

    SuperCom to Report Fourth Quarter and Full Year 2025 Financial Results on April 28th, 2026

    TEL AVIV, Israel, April 23, 2026 /PRNewswire/ -- SuperCom (NASDAQ:SPCB), a global provider of secured solutions for the e-Government, IoT and Cybersecurity sectors, will hold a conference call on Tuesday, April 28, 2026, at 10 a.m. Eastern time (7 a.m. Pacific Time / 5 p.m. IL time) to discuss its financial results for the fourth quarter and year ended December 31, 2025. Financial results will be issued in a press release prior to the call. SuperCom management will host the conference call, followed by a question-and-answer period.Conference Call Dial-In Information:Date: Tuesday, April 28, 2026Time: 10 a.m. Eastern time (7 a.m. Pacific time)U.S. toll-free: 888-506-0062Israel toll-free: 1-80

    4/23/26 9:28:00 AM ET
    $SPCB
    Semiconductors
    Technology

    Groupon Announces Date for First Quarter 2026 Financial Results

    Chicago, Illinois--(Newsfile Corp. - April 23, 2026) - Groupon, Inc. (NASDAQ:GRPN) announced today that it intends to release the company's first quarter 2026 financial results after the market closes on Thursday, May 7, 2026. The company will also host a conference call to answer questions regarding the company's results at 8:00am ET on Friday, May 8, 2026. Investors may submit questions by emailing [email protected] webcast of the conference call can be accessed live at investor.groupon.com. A replay of the webcast will be available through the same link following the conference call, along with other published materials.About Groupon Groupon (www.groupon.com) (NASDAQ:GRPN) is a trusted loc

    4/23/26 7:00:00 AM ET
    $GRPN
    Advertising
    Consumer Discretionary

    Gevo to Report First Quarter 2026 Financial Results on May 7, 2026

    ENGLEWOOD, Colo., April 21, 2026 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ:GEVO) today announced it will host a conference call at 4:30 p.m. ET (2:30 p.m. MT) Thursday, May 7 to report its financial results for the first quarter that ended March 31. To participate in the live call, please call (800) 715-9871 (U.S. toll-free) or (646) 307-1963 (international). Please reference passcode 3527252 to join the call. To listen to the conference call (audio only, non-participating), please register through the following event weblink: https://edge.media-server.com/mmc/p/mngys3a9   A webcast replay will be available after the conference call ends on May 7. The archived webcast will be available in

    4/21/26 9:00:00 AM ET
    $GEVO
    Major Chemicals
    Industrials

    $AFI
    $AGE
    $APLT
    $ASRT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Groupon Inc.

    SC 13G - Groupon, Inc. (0001490281) (Subject)

    12/13/24 10:39:00 AM ET
    $GRPN
    Advertising
    Consumer Discretionary

    SEC Form SC 13G filed by Groupon Inc.

    SC 13G - Groupon, Inc. (0001490281) (Subject)

    12/6/24 2:12:18 PM ET
    $GRPN
    Advertising
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by MongoDB Inc.

    SC 13G/A - MongoDB, Inc. (0001441816) (Subject)

    11/15/24 10:35:42 AM ET
    $MDB
    Computer Software: Prepackaged Software
    Technology

    $AFI
    $AGE
    $APLT
    $ASRT
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Insider Analysis: Purchase at Assertio Holdings Inc. on Jun 6

    Recent insider transactions at Assertio Holdings Inc. have brought attention to the company's stock activity. On June 6, 2024, Mason Heather L purchased $24,250 worth of shares, acquiring 25,000 units at $0.97 per share. This transaction increased Mason Heather L's direct ownership by 13% to 212,650 units, as reported in the SEC Form 4. Several other notable insider transactions have taken place at Assertio Holdings Inc. leading up to this purchase. Patel Ajay, Schwichtenberg Paul, and Schlessinger Sam all converted options into shares and covered exercise/tax liability by utilizing their shares. These transactions resulted in ownership increases of 16%, 20%, and 21%, respectively. Addition

    6/10/24 1:20:50 AM ET
    $ASRT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Insider Analysis: Purchase at Immix Biopharma Inc. on Jun 5

    Recent insider purchases at Immix Biopharma Inc. have caught the attention of investors, with Morris Gabriel S leading the way by acquiring $5,973 worth of shares on June 5, 2024. This transaction involved 3,300 units at a price of $1.81 per share, increasing Gabriel's direct ownership by 1% to 283,334 units, as reported in SEC Form 4. This move indicates Gabriel's confidence in the company's potential and may be seen as a positive signal by market participants. Click here for more details. Looking back at previous insider transactions, we can identify a few interesting patterns. On May 15, 2024, Rachman Ilya M purchased $9,660 worth of shares, comprising 4,300 units at $2.25 per share, whi

    6/10/24 1:09:24 AM ET
    $IMMX
    Biotechnology: Pharmaceutical Preparations
    Health Care